St Jude Medical Inc. (STJ): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

St Jude Medical ( STJ) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole was unchanged today. By the end of trading, St Jude Medical rose 62 cents (1.6%) to $39.71 on average volume. Throughout the day, 3.7 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.5 million shares. The stock ranged in a price between $39.24-$40.02 after having opened the day at $39.28 as compared to the previous trading day's close of $39.09. Other companies within the Health Services industry that increased today were: Kips Bay Medical ( KIPS), up 26.3%, Molina Healthcare ( MOH), up 13.6%, NuVasive ( NUVA), up 12.8%, and Amsurg Corporation ( AMSG), up 7.6%.
  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. St Jude Medical has a market cap of $12.51 billion and is part of the health care sector. The company has a P/E ratio of 15, below the average health services industry P/E ratio of 16.6 and below the S&P 500 P/E ratio of 17.7. Shares are up 16.2% year to date as of the close of trading on Tuesday. Currently there are 16 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Arrhythmia Research Technology ( HRT), down 10%, Thermogenesis Corporation ( KOOL), down 7.2%, Assisted Living Concepts ( ALC), down 5.8%, and Stereotaxis ( STXS), down 5.8%, were all laggards within the health services industry with C.R. Bard ( BCR) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Can Abbott Outperform Despite Alere?

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Labs: Diagnosing Growth in 2017

Abbott Laboratories Can Merge With St. Jude Medical: FTC

FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical